Screening of the Filamin C Gene in a Large Cohort of Hypertrophic Cardiomyopathy Patients

Circulation: Cardiovascular Genetics

Volumn 10, Issue 2, 2017, Pages

  Gómez, Juan ^a   Lorca, Rebeca ^a   Reguero, Julian R ^b   Morís, César ^b,c   Martín, María ^a   Tranche, Salvador ^d   Alonso, Belén ^a   Iglesias, Sara ^a   Alvarez, Victoria ^a   Díaz Molina, Beatriz ^a   Avanzas, Pablo ^a   Coto, Eliecer ^a,c,e  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b Fundación Asturcor   (Spain)

^c UNIVERSITY OF OVIEDO   (Spain)

^d Centro de Salud El Cristo   (Spain)

^e Instituto Carlos IIIFEDER   (Spain)

Author keywords

cardiomyopathy, hypertrophic; filamin C; genetics, diagnostics; genetics, human; next generation sequencing

Indexed keywords

ACTC1 PROTEIN; ALPHA TROPOMYOSIN; BINDING PROTEIN; FILAMIN; FILAMIN C; MYL2 PROTEIN; MYL3 PROTEIN; MYOSIN BINDING PROTEIN C3; MYOSIN HEAVY CHAIN BETA; MYOSIN HEAVY CHAIN BETA7; TNNC1 PROTEIN; TNNI3 PROTEIN; TNNT2 PROTEIN; UNCLASSIFIED DRUG; FLNC PROTEIN, HUMAN;

ADULT; ARTICLE; BIOINFORMATICS; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENE SEGREGATION; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NEXT GENERATION SEQUENCING; NONSENSE MUTATION; PRIORITY JOURNAL; SARCOMERE; CLINICAL TRIAL; GENETICS; HIGH THROUGHPUT SEQUENCING; PENETRANCE;

CARDIOMYOPATHY, HYPERTROPHIC; COHORT STUDIES; FEMALE; FILAMINS; GENETIC TESTING; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MALE; PENETRANCE;

EID: 85018726104     PISSN: 1942325X     EISSN: 19423268     Source Type: Journal    
DOI: 10.1161/CIRCGENETICS.116.001584     Document Type: Article

References (37)

1. Maron BJ, Maron MS. Hypertrophic cardiomyopathy. Lancet. 2013;381:242-255. doi: 10.1016/S0140-6736(12)60397-3.
2. Ho CY, Charron P, Richard P, Girolami F, Van Spaendonck-Zwarts KY, Pinto Y. Genetic advances in sarcomeric cardiomyopathies: state of the art. Cardiovasc Res. 2015;105:397-408. doi: 10.1093/cvr/cvv025.
3. Gómez J, Reguero JR, Morís C, Martín M, Alvarez V, Alonso B, et al. Mutation analysis of the main hypertrophic cardiomyopathy genes using multiplex amplification and semiconductor next-generation sequencing. Circ J. 2014;78:2963-2971.
4. Valdés-Mas R, Gutiérrez-Fernández A, Gómez J, Coto E, Astudillo A, Puente DA, et al. Mutations in filamin C cause a new form of familial hypertrophic cardiomyopathy. Nat Commun. 2014;5:5326. doi: 10.1038/ ncomms6326.
5. Brodehl A, Ferrier RA, Hamilton SJ, Greenway SC, Brundler MA, Yu W, et al; FORGE Canada Consortium. Mutations in FLNC are associated with familial restrictive cardiomyopathy. Hum Mutat. 2016;37:269-279. doi: 10.1002/humu.22942.
6. Golbus JR, Puckelwartz MJ, Dellefave-Castillo L, Fahrenbach JP, Nelakuditi V, Pesce LL, et al. Targeted analysis of whole genome sequence data to diagnose genetic cardiomyopathy. Circ Cardiovasc Genet. 2014;7:751-759. doi: 10.1161/CIRCGENETICS.113.000578.
7. Feng Y, Walsh CA. The many faces of filamin: a versatile molecular scaffold for cell motility and signalling. Nat Cell Biol. 2004;6:1034-1038. doi: 10.1038/ncb1104-1034.
8. Popowicz GM, Schleicher M, Noegel AA, Holak TA. Filamins: promiscuous organizers of the cytoskeleton. Trends Biochem Sci. 2006;31:411-419. doi: 10.1016/j.tibs.2006.05.006.
9. Kley RA, Hellenbroich Y, van der Ven PF, Fürst DO, Huebner A, Bruchertseifer V, et al. Clinical and morphological phenotype of the filamin myopathy: a study of 31 German patients. Brain. 2007;130(pt 12):3250-3264. doi: 10.1093/brain/awm271.
10. Shatunov A, Olivé M, Odgerel Z, Stadelmann-Nessler C, Irlbacher K, van Landeghem F, et al. In-frame deletion in the seventh immunoglobulin-like repeat of filamin C in a family with myofibrillar myopathy. Eur J Hum Genet. 2009;17:656-663. doi: 10.1038/ejhg.2008.226.
11. Duff RM, Tay V, Hackman P, Ravenscroft G, McLean C, Kennedy P, et al. Mutations in the N-terminal actin-binding domain of filamin C cause a distal myopathy. Am J Hum Genet. 2011;88:729-740. doi: 10.1016/j. ajhg.2011.04.021.
12. Fürst DO, Goldfarb LG, Kley RA, Vorgerd M, Olivé M, van der Ven PF. Filamin C-related myopathies: pathology and mechanisms. Acta Neuropathol. 2013;125:33-46. doi: 10.1007/s00401-012-1054-9.
13. O'Mahony C, Jichi F, Pavlou M, Monserrat L, Anastasakis A, Rapezzi C, et al.; Hypertrophic Cardiomyopathy Outcomes Investigators. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD). Eur Heart J. 2014;35:2010-2020. doi: 10.1093/eurheartj/eht439.
14. Riobello C, Gómez J, Gil-Peña H, Tranche S, Reguero JR, de la Hera JM, et al. KCNQ1 gene variants in the risk for type 2 diabetes and impaired renal function in the Spanish Renastur cohort. Mol Cell Endocrinol. 2016;427:86-91. doi: 10.1016/j.mce.2016.03.007.
15. Coto E, Tavira B, Gómez J, Tranche S, Corte CD. Effect of the FTO rs9930506 polymorphism on the main comorbidities of the cardiorenal metabolic syndrome in an elderly Spanish cohort. Cardiorenal Med. 2014;4:82-87. doi: 10.1159/000361054.
16. Gómez J, Reguero JR, Morís C, Alvarez V, Coto E. Non optical semiconductor next generation sequencing of the main cardiac QT-interval duration genes in pooled DNA samples. J Cardiovasc Transl Res. 2014;7:133-137. doi: 10.1007/s12265-013-9516-6.
17. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7:248-249. doi: 10.1038/nmeth0410-248.
18. Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009;4:1073-1081. doi: 10.1038/nprot.2009.86.
19. González-Pérez A, López-Bigas N. Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel. Am J Hum Genet. 2011;88:440-449. doi: 10.1016/j.ajhg.2011.03.004.
20. Kircher M, Witten DM, Jain P, O'Roak BJ, Cooper GM, Shendure J. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 2014;46:310-315. doi: 10.1038/ng.2892.
21. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405-424. doi: 10.1038/gim.2015.30.
22. Tchernitchko D, Goossens M, Wajcman H. In silico prediction of the deleterious effect of a mutation: proceed with caution in clinical genetics. Clin Chem. 2004;50:1974-1978. doi: 10.1373/clinchem.2004.036053.
23. Ackerman MJ. Genetic purgatory and the cardiac channelopathies: Exposing the variants of uncertain/unknown significance issue. Heart Rhythm. 2015;12:2325-2331. doi: 10.1016/j.hrthm.2015.07.002.
24. Gomez J, Reguero JR, Coto E. The ups and downs of genetic diagnosis of hypertrophic cardiomyopathy. Rev Esp Cardiol (Engl Ed). 2016;69:61-68.
25. Andreasen C, Nielsen JB, Refsgaard L, Holst AG, Christensen AH, Andreasen L, et al. New population-based exome data are questioning the pathogenicity of previously cardiomyopathy-associated genetic variants. Eur J Hum Genet. 2013;21:918-928. doi: 10.1038/ejhg.2012.283.
26. Golbus JR, Puckelwartz MJ, Fahrenbach JP, Dellefave-Castillo LM, Wolfgeher D, McNally EM. Population-based variation in cardiomyopathy genes. Circ Cardiovasc Genet. 2012;5:391-399. doi: 10.1161/ CIRCGENETICS.112.962928.
27. Lopes LR, Zekavati A, Syrris P, Hubank M, Giambartolomei C, Dalageorgou C, et al; Uk10k Consortium. Genetic complexity in hypertrophic cardiomyopathy revealed by high-throughput sequencing. J Med Genet. 2013;50:228-239. doi: 10.1136/jmedgenet-2012-101270.
28. Bick AG, Flannick J, Ito K, Cheng S, Vasan RS, Parfenov MG, et al. Burden of rare sarcomere gene variants in the Framingham and Jackson Heart Study cohorts. Am J Hum Genet. 2012;91:513-519. doi: 10.1016/j. ajhg.2012.07.017.
29. Reguero JR, Gómez J, Martín M, Flórez JP, Morís C, Iglesias S, et al. The G263X MYBPC3 mutation is a common and low-penetrant mutation for hypertrophic cardiomyopathy in the region of Asturias (Northern Spain). Int J Cardiol. 2013;168:4555-4556. doi: 10.1016/j.ijcard.2013.06.085.
30. Meredith C, Herrmann R, Parry C, Liyanage K, Dye DE, Durling HJ, et al. Mutations in the slow skeletal muscle fiber myosin heavy chain gene (MYH7) cause laing early-onset distal myopathy (MPD1). Am J Hum Genet. 2004;75:703-708. doi: 10.1086/424760.
31. Schreiber KH, Kennedy BK. When lamins go bad: nuclear structure and disease. Cell. 2013;152:1365-1375. doi: 10.1016/j.cell.2013.02.015.
32. Cattin ME, Muchir A, Bonne G. 'State-of-The-heart' of cardiac laminopathies. Curr Opin Cardiol. 2013;28:297-304. doi: 10.1097/HCO.0b013e32835f0c79.
33. Konersman CG, Bordini BJ, Scharer G, Lawlor MW, Zangwill S, Southern JF, et al. BAG3 myofibrillar myopathy presenting with cardiomyopathy. Neuromuscul Disord. 2015;25:418-422. doi: 10.1016/j. nmd.2015.01.009.
34. Friedrich FW, Wilding BR, Reischmann S, Crocini C, Lang P, Charron P, et al. Evidence for FHL1 as a novel disease gene for isolated hypertrophic cardiomyopathy. Hum Mol Genet. 2012;21:3237-3254. doi: 10.1093/hmg/dds157.
35. Hartmannova H, Kubanek M, Sramko M, Piherova L, Noskova L, Hodanova K, et al. Isolated X-linked hypertrophic cardiomyopathy caused by a novel mutation of the four-and-A-half LIM domain 1 gene. Circ Cardiovasc Genet. 2013;6:543-551. doi: 10.1161/CIRCGENETICS.113.000245.
36. Reinstein E, Gutierrez-Fernandez A, Tzur S, Bormans C, Marcu S, Tayeb-Fligelman E, et al. Congenital dilated cardiomyopathy caused by biallelic mutations in Filamin C. Eur J Hum Genet. 2016;24:1792-1796. doi: 10.1038/ejhg.2016.110.
37. Cuenca S, Ruiz-Cano MJ, Gimeno-Blanes JR, Jurado A, Salas C, Gomez-Diaz I, et al; Inherited Cardiac Diseases Program of the Spanish Cardiovascular Research Network (Red Investigación Cardiovascular). Genetic basis of familial dilated cardiomyopathy patients undergoing heart transplantation. J Heart Lung Transplant. 2016;35:625-635. doi: 10.1016/j.healun.2015.12.014.